Advanced Analysis Free Trading Signals Real Time Alerts
Trade ReWalk Stock Your Capital Is At Risk

ReWalk Robotics Stock Price Jumps 45% on New ‘Breakthrough’ Device

Updated: 5 Nov 2021

ReWalk Robotics pleased investors this morning on the news that its revolutionary ‘ReBoot’ device has been granted designation as a Breakthrough Device from the FDA – sending the stock soaring 45% on Friday in the dawning hours of Friday trading. 

The global manufacturer of robotic medical devices needed the approval to revitalize investor faith and maintain annual growth – currently at 33%. The approval of the ReBoot is a green light for the company’s on-the-fence investors, should the next stages run smoothly. 

The device that is causing all the fuss this morning is the ReBoot; a lightweight, battery-powered orthotic exo-suit intended to aid in walking for those that suffer from reduced mobility. Completely customizable and personalized, and intended for both community and home use – it’s no wonder the device has been aptly named as ‘Breakthrough’. 

new-recommended-broker-banner

Larry Jasinski, CEO of ReWalk stated:

“Breakthrough device designation from the FDA is a critical milestone for the ReBoot, as it provides a more streamlined review pathway that can get this uniquely innovative device to market faster…The ReBoot will give stroke survivors a device customizable for each individual user, giving them the opportunity for regular assistance at home and in the community. ”

ReWalk is currently trading at $1.79, holding onto a strong gain of 38%. The company certainly has potential and was picked up by retail traders in September when the stock rallied over 40%.

Should You Invest in Rewalk Robotics Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .